Evidence map›Paper›PMID 41955068›Full record

ArticleEuropean heart journal2026

Monoclonal gammopathy exclusion in transthyretin amyloid cardiomyopathy: iStopMM estimated glomerular filtration rate-adjusted serum-free light chain ratio cut-offs.

Muhammad Umaid Rauf, Yousuf Razvi, Joshua Bomsztyk, Ana Martinez-Naharro, Carol Whelan, William E Moody, Helen J Lachmann, Ashutosh D Wechalekar, Philip N Hawkins, Marianna Fontana and 1 more

Abstract read
In one paragraph

Article in European heart journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Muhammad Umaid RaufNational Amyloidosis Centre, University College London, Royal Free Hospital, Rowland Hill Street, London NW3 2PF, UK.ORCID 0000-0001-8793-9333
Yousuf RazviNational Amyloidosis Centre, University College London, Royal Free Hospital, Rowland Hill Street, London NW3 2PF, UK.ORCID 0000-0003-4766-3293
Joshua BomsztykNational Amyloidosis Centre, University College London, Royal Free Hospital, Rowland Hill Street, London NW3 2PF, UK.
Ana Martinez-NaharroNational Amyloidosis Centre, University College London, Royal Free Hospital, Rowland Hill Street, London NW3 2PF, UK.
Carol WhelanNational Amyloidosis Centre, University College London, Royal Free Hospital, Rowland Hill Street, London NW3 2PF, UK.
William E MoodyInstitute for Cardiovascular Science, University of Birmingham, Edgbaston, Birmingham, UK.ORCID 0000-0002-2592-618X
Helen J LachmannNational Amyloidosis Centre, University College London, Royal Free Hospital, Rowland Hill Street, London NW3 2PF, UK.
Ashutosh D WechalekarNational Amyloidosis Centre, University College London, Royal Free Hospital, Rowland Hill Street, London NW3 2PF, UK.
Philip N HawkinsNational Amyloidosis Centre, University College London, Royal Free Hospital, Rowland Hill Street, London NW3 2PF, UK.
Marianna FontanaNational Amyloidosis Centre, University College London, Royal Free Hospital, Rowland Hill Street, London NW3 2PF, UK.
Julian D GillmoreNational Amyloidosis Centre, University College London, Royal Free Hospital, Rowland Hill Street, London NW3 2PF, UK.ORCID 0000-0001-6174-9232

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ATTR-CMeGFRiStopMMMonoclonal gammopathyNon-biopsy diagnosis

Identifiers

PMID41955068
PMCPMC13500157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.